ArticleBMC cancer2026

Multi-omics profiling highlights RPLP0 as a potential biomarker for prognosis and response to immunotherapy in clear cell renal cell carcinoma.

Bin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.